ICU Medical Profit Margin 2006-2019 | ICUI
Current and historical gross margin, operating margin and net profit margin for ICU Medical (ICUI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ICU Medical net profit margin as of September 30, 2019 is 5.66%.
| ICU Medical Annual Profit Margins |
|---|
| ICU Medical Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.819B | $1.400B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $149.187B | 27.21 |
| Medtronic (MDT) | Ireland | $148.912B | 20.55 |
| Stryker (SYK) | United States | $75.969B | 25.54 |
| Boston Scientific (BSX) | United States | $59.391B | 28.03 |
| Baxter (BAX) | United States | $41.360B | 25.08 |
| Essilor Luxottica (ESLOY) | France | $32.912B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $29.495B | 18.50 |
| Terumo (TRUMY) | Japan | $27.172B | 33.91 |
| Coloplast (CLPBY) | Denmark | $25.315B | 39.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.204B | 0.00 |
| ResMed (RMD) | United States | $21.492B | 39.65 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.178B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $17.572B | 0.00 |
| Insulet (PODD) | United States | $11.378B | 541.29 |
| Bio-Rad Laboratories (BIO) | United States | $11.123B | 53.39 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.077B | 20.87 |
| Perrigo (PRGO) | Ireland | $6.765B | 12.61 |
| Canopy Growth (CGC) | Canada | $6.616B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.420B | 0.00 |
| Haemonetics (HAE) | United States | $5.992B | 40.49 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 27.26 |
| NuVasive (NUVA) | United States | $3.787B | 29.82 |
| Neogen (NEOG) | United States | $3.465B | 57.97 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.150B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.132B | 0.00 |
| Quidel (QDEL) | United States | $2.821B | 26.77 |
| Aurora Cannabis (ACB) | Canada | $2.691B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.343B | 52.89 |
| Agios Pharmaceuticals (AGIO) | United States | $2.303B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.547B | 0.00 |
| InMode (INMD) | Israel | $1.406B | 0.00 |
| Aphria (APHA) | $1.192B | 0.00 | |
| AtriCure (ATRC) | United States | $1.173B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.126B | 22.55 |
| Phibro Animal Health (PAHC) | United States | $0.980B | 18.35 |
| NanoString Technologies (NSTG) | United States | $0.937B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.791B | 19.75 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.778B | 29.79 |
| TG Therapeutics (TGTX) | United States | $0.778B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.719B | 40.43 |
| Omeros (OMER) | United States | $0.715B | 0.00 |
| Quanterix (QTRX) | United States | $0.707B | 0.00 |
| PetIQ (PETQ) | United States | $0.645B | 15.73 |
| Cerus (CERS) | United States | $0.589B | 0.00 |
| Surmodics (SRDX) | United States | $0.561B | 58.56 |
| HEXO (HEXO) | $0.555B | 0.00 | |
| OraSure Technologies (OSUR) | United States | $0.478B | 28.67 |
| MacroGenics (MGNX) | United States | $0.455B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.442B | 0.00 |
| Owens & Minor (OMI) | United States | $0.416B | 15.40 |
| Utah Medical Products (UTMD) | United States | $0.392B | 28.37 |
| Meridian Bioscience (VIVO) | United States | $0.391B | 13.44 |
| Zynex (ZYXI) | United States | $0.351B | 39.67 |
| BioLife Solutions (BLFS) | United States | $0.329B | 134.08 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.257B | 0.00 |
| United Health Products (UEEC) | United States | $0.256B | 0.00 |
| Bovie Medical (APYX) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.230B | 24.28 |
| Vapotherm (VAPO) | United States | $0.225B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.192B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.171B | 0.00 |
| Chimerix (CMRX) | United States | $0.167B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.162B | 814.00 |
| Female Health (VERU) | United States | $0.142B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.138B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.127B | 8.93 |
| Cytosorbents (CTSO) | United States | $0.126B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 23.08 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.071B | 0.00 |
| Nephros (NEPH) | United States | $0.065B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.059B | 0.00 |
| Surface Oncology (SURF) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.025B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Myomo (MYO) | United States | $0.008B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.003B | 0.00 |
